Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chen, Xing ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA;

ALGORITHM; AREA UNDER THE CURVE; BIOLOGICAL MODEL; GENETIC DATABASE; GENETICS; HUMAN; HUMAN GENOME; LUNG TUMOR; METABOLISM; NEOPLASM; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC;

ALGORITHMS; AREA UNDER CURVE; DATABASES, GENETIC; GENOME, HUMAN; HUMANS; LUNG NEOPLASMS; MICRORNAS; MODELS, GENETIC; NEOPLASMS; RNA, LONG NONCODING; ROC CURVE;

EID: 84939498768     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13186     Document Type: Article

References (113)

1. Crick, F., Barnett, L., Brenner, S. & Watts-Tobin, R. General Nature of the Genetic Code for Proteins. Nature 192, 1227-1232 (1961).
2. Yanofsky, C. Establishing the triplet nature of the genetic code. Cell 128, 815-818 (2007).
3. Bertone, P. et al. Global identification of human transcribed sequences with genome tiling arrays. Science 306, 2242-2246 (2004).
4. Birney, E. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816 (2007).
5. Carninci, P. et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 38, 626-635 (2006).
6. Claverie, J. M. Fewer genes, more noncoding RNA. Science 309, 1529-1530 (2005).
7. Core, L. J., Waterfall, J. J. & Lis, J. T. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322, 1845-1848 (2008).
8. Kapranov, P. et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488 (2007).
9. Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
10. Kapranov, P., Willingham, A. T. & Gingeras, T. R. Genome-wide transcription and the implications for genomic organization. Nat Rev Genet 8, 413-423 (2007).
11. Esteller, M. Non-coding RNAs in human disease. Nat Rev Genet 12, 861-874 (2011).
12. Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: insights into functions. Nat Rev Genet 10, 155-159 (2009).
13. Guttman, M., Russell, P., Ingolia, N. T., Weissman, J. S. & Lander, E. S. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell 154, 240-251 (2013).
14. Cabili, M. N. et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25, 1915-1927 (2011).
15. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22, 1760-1774 (2012).
16. Guttman, M. et al. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol 28, 503-510 (2010).
17. Mercer, T. R., Dinger, M. E., Sunkin, S. M., Mehler, M. F. & Mattick, J. S. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci USA 105, 716-721 (2008).
18. Ponting, C. P., Oliver, P. L. & Reik, W. Evolution and functions of long noncoding RNAs. Cell 136, 629-641 (2009).
19. Borsani, G. et al. Characterization of a murine gene expressed from the inactive X chromosome. Nature 351, 325-329 (1991).
20. Brannan, C. I., Dees, E. C., Ingram, R. S. & Tilghman, S. M. The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10, 28-36 (1990).
21. Brockdorff, N. et al. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 71, 515-526 (1992).
22. Khalil, A. M. et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106, 11667-11672 (2009).
23. Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227 (2009).
24. Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323 (2007).
25. Wang, K. C. et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472, 120-124 (2011).
26. Wapinski, O. & Chang, H. Y. Long noncoding RNAs and human disease. Trends Cell Biol 21, 354-361 (2011).
27. Wilusz, J. E., Sunwoo, H. & Spector, D. L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23, 1494-1504 (2009).
28. Amaral, P. P., Clark, M. B., Gascoigne, D. K., Dinger, M. E. & Mattick, J. S. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res 39, D146-D151 (2011).
29. Chen, G. et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 41, D983-D986 (2013).
30. Mohanty, V., Gokmen-Polar, Y., Badve, S. & Janga, S. C. Role of lncRNAs in health and disease - size and shape matter. Brief Funct Genomics 14, 115-129 (2014).
31. Wang, K. C. & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904-914 (2011).
32. Congrains, A. et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220, 449-455 (2012).
33. Johnson, R. Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiol Dis 46, 245-254 (2012).
34. Pasmant, E., Sabbagh, A., Vidaud, M. & Bieche, I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 25, 444-448 (2011).
35. Zhang, Q., Chen, C.-Y., Yedavalli, V. S. & Jeang, K.-T. NEAT1 Long Noncoding RNA and Paraspeckle Bodies Modulate HIV-1 Posttranscriptional Expression. MBio 4, e00596-00512 (2013).
36. Barsyte-Lovejoy, D. et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 66, 5330-5337 (2006).
37. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
38. Calin, G. A. et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12, 215-229 (2007).
39. Panzitt, K. et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132, 330-342 (2007).
40. de Kok, J. B. et al. DD3PCA3, a very sensitive and specific marker to detect prostate tumors. Cancer Res 62, 2695-2698 (2002).
41. Szell, M., Bata-Csorgo, Z. & Kemeny, L. The enigmatic world of mRNA-like ncRNAs: their role in human evolution and in human diseases. Semin Cancer Biol 18, 141-148 (2008).
42. Zhang, X. et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 88, 5119-5126 (2003).
43. Ji, P. et al. MALAT-1, a novel noncoding RNA, and thymosin β 4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041 (2003).
44. Hung, T. & Chang, H. Y. Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol 7, 582-585 (2010).
45. Maass, P. G., Luft, F. C. & Bahring, S. Long non-coding RNA in health and disease. J Mol Med (Berl) 92, 337-346 (2014).
46. Kogo, R. et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71, 6320-6326 (2011).
47. Li, G. et al. Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma. Biomed Res Int 2014, 780521 (2014).
48. Liu, X. et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 13, 92 (2014).
49. Hrdlickova, B., de Almeida, R. C., Borek, Z. & Withoff, S. Genetic variation in the non-coding genome: Involvement of micro-RNAs and long non-coding RNAs in disease. Biochim. Biophys. Acta. 1842, 1910-1922 (2014).
50. Ariel, I. et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol 53, 320-323 (2000).
51. Godinho, M., Meijer, D., Setyono-Han, B., Dorssers, L. C. & van Agthoven, T. Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells. J. Cell Physiol. 226, 1741-1749 (2011).
52. Godinho, M. et al. Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer. Br J Cancer 103, 1284-1291 (2010).
53. Godinho, M. F. et al. BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib. Br J Cancer 107, 947-955 (2012).
54. Chen, X. & Yan, G.-Y. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics 29, 2617-2624 (2013).
55. Sun, J. et al. Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. Mol Biosyst 10, 2074-2081 (2014).
56. Li, J. et al. A bioinformatics method for predicting long noncoding RNAs associated with vascular disease. Sci China Life Sci 57, 852-857 (2014).
57. Yang, X. et al. A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases. PLoS One 9, e87797 (2014).
58. Zhao, T. et al. Identification of cancer-related lncRNAs through integrating genome, regulome and transcriptome features. Mol Biosyst 11, 126-136 (2015).
59. Zhou, M. et al. Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. Mol Biosyst 11, 760-769 (2015).
60. Dinger, M. E. et al. NRED: a database of long noncoding RNA expression. Nucleic Acids Res 37, D122-D126 (2009).
61. Bu, D. et al. NONCODE v3. 0: integrative annotation of long noncoding RNAs. Nucleic Acids Res 40, D210-D215 (2012).
62. Liu, M.-X., Chen, X., Chen, G., Cui, Q.-H. & Yan, G.-Y. A computational framework to infer human disease-associated long noncoding RNAs. PLoS One 9, e84408 (2014).
63. Lu, M. et al. An analysis of human microRNA and disease associations. PLoS One 3, e3420 (2008).
64. Jiang, Q. et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 37, D98-D104 (2009).
65. Yang, Z. et al. dbDEMC: a database of differentially expressed miRNAs in human cancers. BMC genomics 11, S5 (2010).
66. Wang, Y. et al. Mammalian ncRNA-disease repository: a global view of ncRNA-mediated disease network. Cell Death Dis 4, e765 (2013).
67. Donahue, H. J. & Genetos, D. C. Genomic approaches in breast cancer research. Brief Funct Genomics 12, 391-396 (2013).
68. Karagoz, K., Sinha, R. & Arga, K. Y. Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving Pathways. OMICS 19, 115-130 (2015).
69. Meng, J., Li, P., Zhang, Q., Yang, Z. & Fu, S. A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res 33, 84 (2014).
70. Xu, N., Wang, F., Lv, M. & Cheng, L. Microarray expression profile analysis of long non-coding RNAs in human breast cancer: A study of Chinese women. Biomed Pharmacother 69, 221-227 (2015).
71. Vincent-Salomon, A. et al. X Inactive-Specific Transcript RNA Coating and Genetic Instability of the X Chromosome in BRCA1 Breast Tumors. Cancer Res 67, 5134-5140 (2007).
72. Rodriguez, B. A. et al. Estrogen-mediated epigenetic repression of the imprinted gene cyclin dependent kinase inhibitor 1C in breast cancer cells. Carcinogenesis 32, 812-821 (2011).
73. Bavarva, J. H., Tae, H., Settlage, R. E. & Garner, H. R. Characterizing the genetic basis for nicotine induced cancer development: a transcriptome sequencing study. PLoS One 8, e67252 (2013).
74. Choudhry, H. et al. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2a dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene, doi: 10.1038/onc.2014.378 (2014).
75. White, N. M. et al. Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer. Genome. Biol 15, 429 (2014).
76. Liu, J. et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 22, 2315-2327 (2012).
77. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J Clin 60, 277-300 (2010).
78. Brambilla, E., Travis, W. D., Colby, T., Corrin, B. & Shimosato, Y. The new World Health Organization classification of lung tumours. Eur Respir J 18, 1059-1068 (2001).
79. Scott, W. J., Howington, J., Feigenberg, S., Movsas, B. & Pisters, K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines. Chest 132, 234S-242S (2007).
80. van Zandwijk, N. Neoadjuvant strategies for non-small cell lung cancer. Lung Cancer 34, S145-S150 (2001).
81. Prensner, J. R. & Chinnaiyan, A. M. The emergence of lncRNAs in cancer biology. Cancer Discov 1, 391-407 (2011).
82. Gutschner, T. & Diederichs, S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9, 703-719 (2012).
83. Qi, P. & Du, X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 26, 155-165 (2013).
84. Gutschner, T. et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73, 1180-1189 (2013).
85. Jiang, Y. J. & Bikle, D. D. LncRNA: a new player in 1a, 25 (OH) 2 vitamin D3/VDR protection against skin cancer formation. Exp Dermatol 23, 147-150 (2014).
86. Ji, P., Diederichss & Wang, W. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in earlystage non-small cell lung cancer. Oncogene 22, 8031-8041 (2003).
87. Tano, K. et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 584, 4575-4580 (2010).
88. Zhang, E. et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis 5, e1243 (2014).
89. Shi, X. et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog 54, E1-E12 (2013).
90. Han, D. et al. Long noncoding RNAs: novel players in colorectal cancer. Cancer lett 361, 13-21 (2015).
91. Jiao, S. et al. Estimating the heritability of colorectal cancer. Hum Mol Genet 23, 3898-3905 (2014).
92. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108 (2005).
93. Wood, L. D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007).
94. Brim, H. et al. Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients. PLoS One 7, e40392 (2012).
95. Lassmann, S. et al. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal-and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med (Berl) 85, 293-304 (2007).
96. Xu, C., Yang, M., Tian, J., Wang, X. & Li, Z. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol 39, 169-175 (2011).
97. Yang, M.-H. et al. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta 1852, 166-174 (2015).
98. Zheng, H.-T. et al. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol 7, 3174-3181 (2014).
99. Ji, Q. et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer 111, 736-748 (2014).
100. Ji, Q. et al. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway. PLoS One 8, e78700 (2013).
101. Yoshimizu, T. et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA 105, 12417-12422 (2008).
102. Miroglio, A. et al. Specific hypomethylated CpGs at the IGF2 locus act as an epigenetic biomarker for familial adenomatous polyposis colorectal cancer. Epigenomics 2, 365-375 (2010).
103. Tian, F. et al. Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients. Mol Med Rep 5, 1536-1540 (2012).
104. Cui, H. et al. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62, 6442-6446 (2002).
105. Nakagawa, H. et al. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 98, 591-596 (2001).
106. Tsang, W. P. et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 31, 350-358 (2010).
107. Tanaka, K. et al. Loss of imprinting of long QT intronic transcript 1 in colorectal cancer. Oncology 60, 268-273 (2000).
108. Wang, E. et al. Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Semin Cancer Biol 30, 4-12 (2015).
109. Wang, E. Understanding genomic alterations in cancer genomes using an integrative network approach. Cancer letters 340, 261-269 (2013).
110. Li, Y. et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Res 42, D1070-D1074 (2014).
111. Li, J.-H., Liu, S., Zhou, H., Qu, L.-H. & Yang, J.-H. starBase v2. 0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42, D92-D97 (2013).
112. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289-300 (1995).
113. Wang, D., Wang, J., Lu, M., Song, F. & Cui, Q. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics 26, 1644-1650 (2010).